| scholarly article | Q13442814 |
| P2093 | author name string | Eric T Harvill | |
| Mylisa R Pilione | |||
| P2860 | cites work | Interleukin-10 | Q28263225 |
| Multiple defects of immune cell function in mice with disrupted interferon-gamma genes | Q28267397 | ||
| IL-10 inhibits cytokine production by activated macrophages | Q29619453 | ||
| Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells. | Q30449654 | ||
| Pregenomic comparative analysis between bordetella bronchiseptica RB50 and Bordetella pertussis tohama I in murine models of respiratory tract infection | Q34002563 | ||
| Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection | Q34005187 | ||
| Mechanisms of Bordetella pathogenesis | Q34100028 | ||
| CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity | Q34529549 | ||
| Role of Bordetella O antigen in respiratory tract infection | Q34531338 | ||
| BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model | Q34533729 | ||
| IL-10-producing T cells suppress immune responses in anergic tuberculosis patients | Q35159232 | ||
| Interferon-gamma activation of polymorphonuclear neutrophil function | Q35750735 | ||
| Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussi | Q36369855 | ||
| Role of antibodies in immunity to Bordetella infections | Q39741874 | ||
| Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. | Q40636724 | ||
| pagP is required for resistance to antibody-mediated complement lysis during Bordetella bronchiseptica respiratory infection | Q40763994 | ||
| Modulation of host immune responses, induction of apoptosis and inhibition of NF-kappaB activation by the Bordetella type III secretion system | Q40894557 | ||
| The BvgAS virulence control system regulates type III secretion in Bordetella bronchiseptica | Q41025688 | ||
| The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta | Q41600919 | ||
| IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells | Q41684085 | ||
| Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes. | Q42981482 | ||
| Bordetella bronchiseptica PagP is a Bvg‐regulated lipid A palmitoyl transferase that is required for persistent colonization of the mouse respiratory tract | Q43544576 | ||
| IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages | Q44173170 | ||
| Bordetella type III secretion and adenylate cyclase toxin synergize to drive dendritic cells into a semimature state | Q44987484 | ||
| Antibody-mediated bacterial clearance from the lower respiratory tract of mice requires complement component C3. | Q47199485 | ||
| The complex mechanism of antibody-mediated clearance of Bordetella from the lungs requires TLR4. | Q47687255 | ||
| Bordetella type III secretion modulates dendritic cell migration resulting in immunosuppression and bacterial persistence | Q47724256 | ||
| In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha | Q57339973 | ||
| IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi | Q58843169 | ||
| Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice | Q73082077 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| Bordetella bronchiseptica | Q137446 | ||
| P304 | page(s) | 1043-1049 | |
| P577 | publication date | 2006-02-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance | |
| P478 | volume | 74 |
| Q34446897 | A Type VI secretion system encoding locus is required for Bordetella bronchiseptica immunomodulation and persistence in vivo |
| Q37075478 | Active and passive immunizations with Bordetella colonization factor A protect mice against respiratory challenge with Bordetella bronchiseptica |
| Q90626707 | Analysis of the lung microbiota in dogs with Bordetella bronchiseptica infection and correlation with culture and quantitative polymerase chain reaction |
| Q58758919 | Blood or Serum Exposure Induce Global Transcriptional Changes, Altered Antigenic Profile, and Increased Cytotoxicity by Classical Bordetellae |
| Q33384933 | Boolean network simulations for life scientists |
| Q33590435 | Bordetella evades the host immune system by inducing IL-10 through a type III effector, BopN |
| Q91780268 | Canine Infectious Respiratory Disease |
| Q58583885 | Colonization Limits Efficacy, but Not Immunogenicity, of Live-Attenuated Influenza Virus Vaccine and Enhances Pathogenesis After Influenza Challenge |
| Q40033232 | Constraint-based network model of pathogen-immune system interactions |
| Q36746359 | Decreased leukocyte accumulation and delayed Bordetella pertussis clearance in IL-6-/- mice |
| Q39335351 | Development and characterization of attenuated metabolic mutants of Bordetella bronchiseptica for applications in vaccinology. |
| Q92335399 | Enhancement of immune response against Bordetella spp. by disrupting immunomodulation |
| Q41453869 | Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary Yersinia pestis infection |
| Q36591125 | Generating super-shedders: co-infection increases bacterial load and egg production of a gastrointestinal helminth |
| Q37529638 | IL-10 induction by Bordetella parapertussis limits a protective IFN-gamma response |
| Q44797322 | Identification of a new protective antigen of Bordetella pertussis |
| Q33672341 | Immune regulation of a chronic bacteria infection and consequences for pathogen transmission |
| Q33402920 | Inefficient Toll-like receptor-4 stimulation enables Bordetella parapertussis to avoid host immunity |
| Q34484529 | Interleukin-1 Receptor Signaling Is Required To Overcome the Effects of Pertussis Toxin and for Efficient Infection- or Vaccination-Induced Immunity against Bordetella pertussis |
| Q43078103 | Lack of cross-protection against Bordetella holmesii after pertussis vaccination |
| Q33287189 | Modeling systems-level regulation of host immune responses |
| Q34130164 | Network model of immune responses reveals key effectors to single and co-infection dynamics by a respiratory bacterium and a gastrointestinal helminth. |
| Q33502706 | O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies |
| Q35805470 | Phenotypic modulation of the virulent Bvg phase is not required for pathogenesis and transmission of Bordetella bronchiseptica in swine |
| Q35042275 | Resident microbiota affect Bordetella pertussis infectious dose and host specificity |
| Q58773207 | Respiratory Carriage is Associated with Broad Phenotypic Alterations of Peripheral CD4⁺CD25⁺ T Cells and Differentially Affects Immune Responses to Secondary Non-Infectious and Infectious Stimuli in Mice |
| Q37333410 | Role of the type III secretion system in a hypervirulent lineage of Bordetella bronchiseptica. |
| Q51153411 | Seasonal breeding drives the incidence of a chronic bacterial infection in a free-living herbivore population. |
| Q37066697 | Single-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4+ cells are required at the time of challenge for optimal protection |
| Q42080014 | Snapshot of spatio-temporal cytokine responses to single and co-infections with helminths and bacteria. |
| Q40022559 | Supplementation of whole-cell pertussis vaccines with lipopolysaccharide analogs: modification of vaccine-induced immune responses |
| Q37643836 | The Bordetella bronchiseptica type III secretion system is required for persistence and disease severity but not transmission in swine |
| Q37457083 | The Bordetella type III secretion system effector BteA contains a conserved N-terminal motif that guides bacterial virulence factors to lipid rafts |
| Q42613134 | The O antigen is a critical antigen for the development of a protective immune response to Bordetella parapertussis |
| Q37534202 | Toll-like receptor 4 limits transmission of Bordetella bronchiseptica. |
| Q36191639 | Transcriptional profiling of Bordetella pertussis reveals requirement of RNA chaperone Hfq for Type III secretion system functionality. |
| Q35913617 | Use of a genetically defined double mutant strain of Bordetella bronchiseptica lacking adenylate cyclase and type III secretion as a live vaccine |
| Q36662611 | Variation in host susceptibility and infectiousness generated by co-infection: the myxoma-Trichostrongylus retortaeformis case in wild rabbits. |
| Q37627029 | Vesicular Stomatitis Virus-Vectored Multi-Antigen Tuberculosis Vaccine Limits Bacterial Proliferation in Mice following a Single Intranasal Dose |
| Q37382931 | Virulence factor secretion and translocation by Bordetella species |
Search more.